Two important trials, or I’d like to figure two more important trials. The first one is the European Carotid Surgical Trial 2. An interim analysis, two years interim analysis of this trial showed that the best medical treatment is comparable to carotid revascularization, whether asymptomatic or symptomatic with stenosis more than 50%. But the patient should have low to intermediate risk estimated by carotid score or CAS score...
Two important trials, or I’d like to figure two more important trials. The first one is the European Carotid Surgical Trial 2. An interim analysis, two years interim analysis of this trial showed that the best medical treatment is comparable to carotid revascularization, whether asymptomatic or symptomatic with stenosis more than 50%. But the patient should have low to intermediate risk estimated by carotid score or CAS score. And another trial is the CREST-2 trial, which actually has two parallel lines together. The first line comparing best medical management together with stenosis and carotid stenting with best medical management and the other line comparing that best medical management together with carotid endarterectomy plus best medical management. And the result showed that the carotid artery stenting together with best medical management had a better result than best medical management alone. So the carotid artery stenting together with best medical management had the lowest stroke risk by 2.8 percent in comparison to six percent in the arm of the best medical management. While in the surgical arm, the surgery and best medical management in comparison to best medical management achieved comparable results. So this means that best medical management is the default, so you should give it to all patients and best medical management if combined with carotid artery stenting will achieve better results in asymptomatic carotid stenosis.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.